Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitrendipine and metabolic balance.

L A Ferrara1, T Marotta

  • 1Institute of Internal Medicine and Metabolic Diseases, Second Medical School, University of Naples, Italy.

Journal of Cardiovascular Pharmacology
|January 1, 1991
PubMed
Summary

Nitrendipine, a calcium-entry blocker, does not negatively impact glucose or lipid levels in hypertensive patients. This makes it a safe choice for managing high blood pressure, especially in those with metabolic concerns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is increased uric acid a risk factor or a defensive response? The Campania Salute Network.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

Use of a flow-diverting stent for ruptured dissecting aneurysm treatment in a patient with sickle cell disease.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2015
Same author

Low-lipid diet reduces frequency and severity of acute migraine attacks.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2015
Same author

Type of myocardial infarction presentation in patients with chronic kidney disease.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

Enhancing brain lesions after endovascular treatment of aneurysms.

AJNR. American journal of neuroradiology·2014

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Hypertension is often associated with abnormal glucose and lipoprotein metabolism.
  • Cardiovascular disease risk reduction in hypertensive patients is enhanced by improved glucose and lipid levels.
  • Antihypertensive medications with favorable metabolic profiles are crucial for patients with metabolic impairment.

Purpose of the Study:

  • To evaluate the metabolic effects of nitrendipine, a dihydropiridine calcium-entry blocker.
  • To determine if nitrendipine impacts glucose, insulin, and lipid serum levels in hypertensive patients.

Main Methods:

  • Clinical study comparing metabolic parameters before and after nitrendipine administration.
  • Assessment of fasting glucose and insulin levels.

Related Experiment Videos

  • Evaluation of glucose and insulin response to an oral carbohydrate challenge.
  • Measurement of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels.

    • Main Results:

    • Nitrendipine did not alter fasting glucose or insulin levels.
    • Glucose and insulin response to oral carbohydrate challenge remained unaffected.
    • Serum cholesterol, triglyceride, and HDL cholesterol levels showed no significant changes.
    • Nitrendipine demonstrated no adverse metabolic side effects.

    Conclusions:

    • Nitrendipine can be safely prescribed for hypertension when a calcium-entry blocker is indicated.
    • The drug's lack of adverse metabolic effects is particularly beneficial for hypertensive patients with existing metabolic issues.